Penumbra General and Administrative Expenses 2011-2026 | PEN

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Penumbra

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
663 M	574 M	506 M	450 M	378 M	287 M	273 M	226 M	184 M	148 M	102 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
663 M	102 M	345 M

Quarterly General and Administrative Expenses Penumbra

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
169 M	160 M	153 M	140 M	142 M	144 M	126 M	127 M	123 M	-	109 M	115 M	111 M	-	94.4 M	90.6 M	79.8 M	-	76.2 M	59.9 M	74.5 M	-	69.3 M	67.7 M	61.1 M	-	55.9 M	54.8 M	54.5 M	-	46 M	44.2 M	42.7 M	-	37.7 M	35.9 M	33.1 M	-	26.8 M	26.4 M	19.5 M	-	16.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
169 M	16.6 M	81.9 M

General and Administrative Expenses of other stocks in the Medical devices industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
Acutus Medical AFIB	14.1 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	7.11 M	-	3.58 %	$ 2.21 M	USA
Alphatec Holdings ATEC	499 M	$ 12.42	-4.46 %	$ 1.86 B	USA
GenMark Diagnostics, Inc. GNMK	25.6 M	-	-	$ 1.77 B	USA
Aziyo Biologics AZYO	14.1 M	-	1.37 %	$ 20.5 M	USA
Obalon Therapeutics, Inc. OBLN	8.78 M	-	-5.86 %	$ 30.6 M	USA
Bruker Corporation BRKR	894 M	$ 38.55	0.13 %	$ 5.74 K	USA
Cognyte Software Ltd. CGNT	163 M	$ 8.31	1.4 %	$ 597 M	Israel
Conformis CFMS	28.8 M	-	-	$ 16.4 M	USA
AdaptHealth Corp. AHCO	382 M	$ 9.61	-0.62 %	$ 1.3 B	USA
Apollo Endosurgery APEN	20.6 M	-	-	$ 475 M	USA
Electromed ELMD	39.3 M	$ 24.26	-0.12 %	$ 205 M	USA
Cardiovascular Systems CSII	171 M	-	0.15 %	$ 844 M	USA
CONMED Corporation CNMD	132 M	$ 41.66	-3.09 %	$ 1.29 B	USA
EDAP TMS S.A. EDAP	5.9 M	$ 4.19	-1.41 %	$ 156 M	France
Cutera CUTR	63.3 M	-	-10.19 %	$ 1.99 M	USA
CryoLife, Inc. CRY	141 M	-	-4.14 %	$ 702 M	USA
Avinger AVGR	14.1 M	-	-20.74 %	$ 369 K	USA
FONAR Corporation FONR	23.5 M	$ 18.59	0.3 %	$ 122 M	USA
AxoGen AXGN	44.6 M	$ 29.15	-0.24 %	$ 1.34 B	USA
Apyx Medical Corporation APYX	22.2 M	$ 3.27	-0.82 %	$ 113 M	USA
Axonics Modulation Technologies AXNX	40.2 M	-	-	$ 3.31 B	USA
Dynatronics Corporation DYNT	8.46 M	-	14.99 %	$ 929 K	USA
Eargo EAR	54.3 M	-	-	$ 10.2 M	USA
Soliton, Inc. SOLY	8.46 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	4.88 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	8.5 M	-	0.03 %	$ 1.58 B	Israel
Second Sight Medical Products EYES	806 K	-	-0.97 %	$ 54.4 M	USA
Accuray Incorporated ARAY	47.9 M	$ 0.5	-4.78 %	$ 51.4 M	USA
Misonix, Inc. MSON	18 M	-	-	$ 462 M	USA
Neovasc NVCN	14.7 M	-	-	$ 111 M	Canada
Cytosorbents Corporation CTSO	35 M	$ 0.81	1.91 %	$ 44.1 M	USA
Align Technology ALGN	1.76 B	$ 175.78	-3.51 %	$ 13.2 B	USA
Intersect ENT, Inc. XENT	98.6 M	-	-	$ 955 M	USA
Butterfly Network BFLY	39.8 M	$ 3.7	-8.31 %	$ 783 M	USA
BIOLASE BIOL	10.2 M	-	-13.19 %	$ 166 K	USA
Abbott Laboratories ABT	12.3 B	$ 110.91	-1.94 %	$ 193 B	USA
InMode Ltd. INMD	8.41 M	$ 13.49	-0.55 %	$ 872 M	Israel
BioSig Technologies BSGM	11.6 M	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	6.89 B	$ 72.61	0.55 %	$ 107 B	USA
IRadimed Corporation IRMD	15.9 M	$ 100.27	-4.6 %	$ 1.27 B	USA
IRIDEX Corporation IRIX	8.75 M	$ 1.4	-0.71 %	$ 22.6 M	USA
Pulmonx Corporation LUNG	102 M	$ 1.61	12.07 %	$ 63 M	USA
OrthoPediatrics Corp. KIDS	120 M	$ 17.55	-5.03 %	$ 412 M	USA
Medtronic PLC MDT	10.8 B	$ 92.93	-2.8 %	$ 119 B	USA
Helius Medical Technologies HSDT	9.27 M	$ 2.26	-2.16 %	$ 1.37 M	USA
Medigus Ltd. MDGS	9.96 M	-	10.28 %	$ 55.5 M	Israel
Edwards Lifesciences Corporation EW	2.09 B	$ 83.7	-1.78 %	$ 48.9 B	USA